PHI with Fibroadenoma excision
How does this condition affect your private health insurance?
Fibroadenomentfernung refers to the surgical excision of a fibroadenoma, a common, benign, non-cancerous tumor of the breast. These lumps are typically firm, rubbery, and movable, often occurring in younger women. Removal is usually recommended if the fibroadenoma grows rapidly, causes discomfort, or if there's diagnostic uncertainty. The procedure, often performed under local or general anesthesia, involves a small incision to carefully remove the mass. Post-operative recovery is generally swift, with most individuals returning to normal activities within a few days to a week. The primary aim is complete removal and histological confirmation of its benign nature, offering excellent long-term prognosis.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute recovery typically 1-2 weeks post-surgery; the fibroadenoma itself may have been present for months to years prior to removal.
Duration of Illness (Lifetime)
A single, usually curative event for the specific fibroadenoma; however, new fibroadenomas can develop over a lifetime, potentially requiring further intervention.
Cost of Treatment (Initial)
Approximately $3,000 - $10,000 USD, varying by region, facility, and insurance coverage. Includes surgeon's fees, anesthesia, facility costs, and pathology.
Cost of Treatment (Lifetime)
Typically equivalent to the cost of first occurrence if no new fibroadenomas develop; can increase significantly if multiple surgical interventions are required over time.
Mortality Rate
Less than 0.01%, extremely rare for this routine, low-risk surgical procedure.
Risk of Secondary Damages
Low (5-15%), including risks such as infection, hematoma, seroma, persistent pain, scarring, or rare nerve damage affecting sensation.
Probability of Full Recovery
Very high (95-99%), as the benign mass is typically completely removed, leading to full resolution of the specific lump.
Underlying Disease Risk
Very low (less than 1%). Fibroadenomas are generally isolated benign findings and not typically associated with other systemic underlying diseases, although other breast conditions may co-exist.